In the last week of April, pediatric COVID-19 cases were up 61% from the period two weeks prior, according to data published by the American Academy of Physicians.
Though coronavirus cases among children were still down from a peak of about 1.15 millio…
Due in large part to investment losses, Kaiser Permanente posted a net loss of $961 million during the first quarter of this year, a stark contrast to the net income of $2 billion that was posted in 2021, according to financial data the organization re…
BOSTON – At ATA2022, BlueJeans announced the next stage in its telehealth services offerings through a more personalized experience for providers and patients.
Providers can now embed the telehealth function on their website rather than through an app…
In two separate transactions, insurer Centene is divesting two of its pharmacy businesses, Magellan Rx and PANTHERx Rare. The company has signed two definitive agreement, and will sell the former to Prime Therapeutics and the latter to a consortium of …
Cigna has rolled out a new service geared toward improving health outcomes for patients with complex cancers. Powered by Evernorth, the company’s health services business, the service connects patients and their community oncologists with cancer subspe…
The U.S. Food and Drug Administration has limited the use of the Johnson & Johnson Janssen COVID-19 vaccine due to rare blood clotting instances of thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.
Three days after a leaked Roe v. Wade draft opinion was made public, the American Medical Association has released a statement expressing its concern over what a final ruling would mean for government interference in the patient-physician relationship.
Medicaid managed care services are mainly concentrated across a small handful of providers, a trend that’s happening at a time when the managed care space is becoming more lucrative for health insurance providers, according to findings in a Health Affa…
Drug manufacturer Johnson & Johnson has filed a lawsuit against drug benefit company SaveOnSP for allegedly taking advantage of a J&J program that covers out-of-pocket costs for patients who use some of the more expensive prescription drugs.
CVS Health beat industry expectations by bringing in $2.3 billion in profit in the first quarter of this year, a slight increase over the $2.2 billion profit posted during the same time last year, according to an earnings report filed this week.
